- Posted October 04, 2011
- Tweet This | Share on Facebook
Pharmaceutical Pfizer warns against counterfeit drugs
By Linda A. Johnson
AP Business Writer
Pfizer Inc. and a pharmacy standards group are teaming to warn consumers about the risks of counterfeit prescription medicines, which endanger the public and take money from both pharmacies and legitimate drugmakers.
Pfizer Inc., whose impotence pill Viagra is widely counterfeited, and the National Association of Boards of Pharmacy last week announced the start of an educational campaign to explain the dangers of counterfeit drugs and help people find legitimate pharmacies online.
The effort includes a website called www.AWARERx.com, a video series on a new YouTube channel called www.youtube.com/ spotfakemeds, and takeovers of websites counterfeiters have previously used to sell knock-offs of Pfizer medicines.
Counterfeit drugs can be very dangerous, containing toxic substances such as rat poison or lead, or they can have the wrong amount of the real drug's active ingredient. In addition, people who buy medicines from illegal online pharmacies risk financial fraud and identity theft if they provide credit card or other personal information.
New York-based Pfizer said counterfeit versions of Viagra have been sold in at least 101 countries.
Pfizer and the pharmacy association estimated that worldwide sales of counterfeit medicines topped $75 billion last year, up 90 percent since 2005. Meanwhile, one in six Americans bought medicines on the Internet last year.
Among other advice, the U.S. Food and Drug Administration urges consumers to check Internet pharmacy sites for a seal indicating they are licensed pharmacies and sell approved medicines. The blue, oval-shaped seal reads "National Association Boards of Pharmacy," around the red letters VIPPS, short for Verified Internet Pharmacy Practice Sites. A list of sites with that accreditation is at www.VIPPSpharmacies.net.
Published: Tue, Oct 4, 2011
headlines Detroit
- Lawsuits between prediction markets and states now spans nearly half of U.S.
- Supreme Court reform gathers momentum
- Narrow Mail-in Voting Ruling by Supreme Court Doesn’t Address Constitutionality of Trump’s Executive Order
- ABA joins NASS and to mobilize lawyers as poll workers for midterm elections
- Daily Briefs
headlines National
- Legal writers can benefit from a Zen writing approach and some Hemingway—and so can their readers
- ACLU and BigLaw firm use ‘Orange is the New Black’ in hashtag effort to promote NY jail reform
- Why the next competitive advantage in the AI era is partnership, not just technology
- Things I wish my spouse had told me before they died
- Troutman Pepper Locke associate files discrimination lawsuit against firm
- Jay-Z’s extortion suit against lawyer in withdrawn rape case faces skepticism from judge




